| 产品描述: | Zinc Gluconate 具有研究普通感冒、癌症和营养补充剂作为食品添加剂的潜力。 |
| 体内研究: |
Zinc Gluconate (5.13-30.78 mg/kg; 尾静脉注射; 3 天) 在抗生素和 LPS 诱导的小鼠肠黏膜屏障损伤模型中具有保护作用。 Zinc Gluconate (33 mM; 鼻腔冲洗; 单次给药) 会导致雌性 CD1 小鼠嗅觉功能受损。 |
| 参考文献: |
1. Poiraud C, et al. Zinc gluconate is an agonist of peroxisome proliferator-activated receptor-α in the epidermis. Exp Dermatol. 2012 May;21(5):347-51. 2. Wang Y, et al. Protective effect of zinc gluconate on intestinal mucosal barrier injury in antibiotics and LPS-induced mice. Front Microbiol. 2024 May 23;15:1407091. 3. Duncan-Lewis CA, et al. Effects of zinc gluconate and 2 other divalent cationic compounds on olfactory function in mice. Comp Med. 2011 Aug;61(4):361-5. 4. Hao, Yahui, et al. Zinc gluconate and its side-effects in clinical use.5. Wang YC, et al. Determination of the median lethal dose of zinc gluconate in mice and safety evaluation. BMC Pharmacol Toxicol. 2024 Feb 5;25(1):15. |
| 溶解性: |
易溶于水,不溶于乙醇,氯仿和乙醚。 |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.195 ml |
10.973 ml |
21.945 ml |
| 5 mM |
0.439 ml |
2.195 ml |
4.389 ml |
| 10 mM |
0.219 ml |
1.097 ml |
2.195 ml |
| 50 mM |
0.044 ml |
0.219 ml |
0.439 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |